Operator of a pharmaceutical wholesaler intended to supply generic, branded, and unlicensed medicines to pharmacies, dis
Operator of a pharmaceutical wholesaler intended to supply generic, branded, and unlicensed medicines to pharmacies, dispensing doctors, hospitals, pharmaceutical wholesalers, and buying groups.
Distributors (Healthcare)📍 Glasgow, United KingdomFounded 2012
Current Valuation
$936.3M
as of 2022-Q2
PRIVATE
QL Price
$936.3M
0% vs last round
QuantLogix's current estimate for Target Healthcare, published 2026-09-27 — in line with the last disclosed round of $936.3M (2022-Q2).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$936.3M
2022-Q2
weight 0.05
How this price has held up
No round has priced for Target Healthcare since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Target Healthcare, 2026-09-27 (72d27aba5bf7e16e).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Target Healthcare going public?
No. Target Healthcare is private and has not filed to go public. There is no S-1 on file.
What is Target Healthcare's valuation in 2026?
Target Healthcare is valued at $936.3M as of 2022-Q2, set by its Later Stage VC ($164.08M, Apr 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Target Healthcare filed an S-1?
No public S-1 is on file for Target Healthcare.
How much has Target Healthcare raised?
Target Healthcare has raised $263.15M in total, most recently a Later Stage VC of $164.08M in Apr 2022.
Is Target Healthcare publicly traded — can you buy Target Healthcare stock?
No. Target Healthcare is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Target Healthcare on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2012
HQ
Glasgow, United Kingdom
Employees
300
Total Raised
$263.15M
Last Round
Later Stage VC — $164.08M (Apr 2022)
IPO Status
private
Fundraising Status
Later Stage VC · $164.08M · 4y 5mo ago
privateTotal raised $263.15M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Later Stage VC
$164.08M
Apr 2022
—
$936.3M
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Target Healthcare — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-27. Re-checked weekly.
Talent Signal
Hiring trend
▲ Hiring uptrend
+3900% vs 2026-08
Open roles
120
via workday
Product-build share
13%
engineering, research, product, design
Trajectory
expanding
go-to-market push — Only 13% of open roles build product — hiring is concentrated in sales/marketing/ops (80 of 120 open roles are other).
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Target Security SpecialistTarget Security SpecialistTarget Security SpecialistSr Target Security Specialist - Regional Distribution Center, West Jefferson, OHData AnalystSr Engineer- Search
Counted from Target Healthcare's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
MedicalHealth CarePharmaceutical
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q2. Refreshed quarterly.